HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brutkiewicz, R. R. Search for Related Content PubMed PubMed Citation Articles by Brutkiewicz, R. R.

CD1d Ligands: The Good, the Bad, and the Ugly¹

Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202; and The Walther Oncology Center, Walther Cancer Institute, Indianapolis, IN 46208

The MHC class I-like CD1d glycoprotein is a member of the CD1 family of Ag-presenting molecules and is responsible for the selection of NKT cells. A number of ligands that can be presented by CD1d to NKT or other CD1d-restricted T cells have been identified. These include glycolipids from a marine sponge, bacterial glycolipids, normal endogenous glycolipids, tumor-derived phospholipids and glycolipids, and nonlipidic molecules. The presentation of many of these molecules can have immunopotentiating effects, such as serving as an adjuvant against malaria or resulting in a more rapid clearance of certain virus infections. They can also be protective in autoimmune diseases or cancer or can be deleterious. This review will highlight these ligands in a discussion of their potential use against (and role in the pathogenesis of) these diseases.

This article has been cited by other articles:

				J. D. Silk, M. Salio, B. G. Reddy, D. Shepherd, U. Gileadi, J. Brown, S. H. Masri, P. Polzella, G. Ritter, G. S. Besra, et al. Cutting Edge: Nonglycosidic CD1d Lipid Ligands Activate Human and Murine Invariant NKT Cells J. Immunol., May 15, 2008; 180(10): 6452 - 6456. [Abstract] [Full Text] [PDF]

				M. Pichavant, S. Goya, E. H. Meyer, R. A. Johnston, H. Y. Kim, P. Matangkasombut, M. Zhu, Y. Iwakura, P. B. Savage, R. H. DeKruyff, et al. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17 J. Exp. Med., February 18, 2008; 205(2): 385 - 393. [Abstract] [Full Text] [PDF]

				A. Strom, M. Wigren, A. Hultgardh-Nilsson, A. Saxena, M. F. Gomez, S. Cardell, G. N. Fredrikson, and J. Nilsson Involvement of the CD1d Natural Killer T Cell Pathway in Neointima Formation After Vascular Injury Circ. Res., October 12, 2007; 101(8): e83 - e89. [Abstract] [Full Text] [PDF]

				B. Stijlemans, T. N. Baral, M. Guilliams, L. Brys, J. Korf, M. Drennan, J. Van Den Abbeele, P. De Baetselier, and S. Magez A Glycosylphosphatidylinositol-Based Treatment Alleviates Trypanosomiasis-Associated Immunopathology J. Immunol., September 15, 2007; 179(6): 4003 - 4014. [Abstract] [Full Text] [PDF]

				O. Adotevi, B. Vingert, L. Freyburger, P. Shrikant, Y.-C. Lone, F. Quintin-Colonna, N. Haicheur, M. Amessou, A. Herbelin, P. Langlade-Demoyen, et al. B Subunit of Shiga Toxin-Based Vaccines Synergize with {alpha}-Galactosylceramide to Break Tolerance against Self Antigen and Elicit Antiviral Immunity J. Immunol., September 1, 2007; 179(5): 3371 - 3379. [Abstract] [Full Text] [PDF]

				J. Grunewald and A. Eklund State of the Art. Role of CD4+ T Cells in Sarcoidosis Proceedings of the ATS, August 15, 2007; 4(5): 461 - 464. [Abstract] [Full Text] [PDF]

				A. Thedrez, C. de Lalla, S. Allain, L. Zaccagnino, S. Sidobre, C. Garavaglia, G. Borsellino, P. Dellabona, M. Bonneville, E. Scotet, et al. CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells Blood, July 1, 2007; 110(1): 251 - 258. [Abstract] [Full Text] [PDF]

				V. PARIETTI, H. CHIFFLOT, S. MULLER, and F. MONNEAUX Regulatory T Cells and Systemic Lupus Erythematosus Ann. N.Y. Acad. Sci., June 1, 2007; 1108(1): 64 - 75. [Abstract] [Full Text] [PDF]

				C. McCarthy, D. Shepherd, S. Fleire, V. S. Stronge, M. Koch, P. A. Illarionov, G. Bossi, M. Salio, G. Denkberg, F. Reddington, et al. The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation J. Exp. Med., May 14, 2007; 204(5): 1131 - 1144. [Abstract] [Full Text] [PDF]

				A. J. Zullo, K. Benlagha, A. Bendelac, and E. J. Taparowsky Sensitivity of NK1.1-Negative NKT Cells to Transgenic BATF Defines a Role for Activator Protein-1 in the Expansion and Maturation of Immature NKT Cells in the Thymus J. Immunol., January 1, 2007; 178(1): 58 - 66. [Abstract] [Full Text] [PDF]

				D. I. Godfrey, M. J. McConville, and D. G. Pellicci Chewing the fat on natural killer T cell development J. Exp. Med., October 2, 2006; 203(10): 2229 - 2232. [Abstract] [Full Text] [PDF]